D.E. Shaw & Co’s Arcosa ACA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$979K Sell
9,224
-25,310
-73% -$2.88M ﹤0.01% 3463
2025
Q4
$3.67M Sell
34,534
-31,085
-47% -$3.14M ﹤0.01% 2569
2025
Q3
$6.15M Buy
65,619
+54,483
+489% +$5.07M ﹤0.01% 2034
2025
Q2
$966K Buy
11,136
+4,794
+76% +$401K ﹤0.01% 3252
2025
Q1
$489K Sell
6,342
-6,384
-50% -$586K ﹤0.01% 3521
2024
Q4
$1.23M Sell
12,726
-23,111
-64% -$2.32M ﹤0.01% 3087
2024
Q3
$3.4M Sell
35,837
-47,889
-57% -$4.18M ﹤0.01% 2268
2024
Q2
$6.98M Buy
83,726
+60,199
+256% +$5.02M 0.01% 1607
2024
Q1
$2.02M Sell
23,527
-28,505
-55% -$2.32M ﹤0.01% 2622
2023
Q4
$4.3M Sell
52,032
-94,421
-64% -$6.93M ﹤0.01% 2030
2023
Q3
$10.5M Buy
146,453
+1,144
+0.8% +$86.8K 0.01% 1257
2023
Q2
$11M Buy
145,309
+63,274
+77% +$4.25M 0.01% 1264
2023
Q1
$5.18M Buy
82,035
+52,131
+174% +$3.06M 0.01% 1912
2022
Q4
$1.62M Sell
29,904
-43,230
-59% -$2.57M ﹤0.01% 3096
2022
Q3
$4.18M Buy
73,134
+39,739
+119% +$2.2M 0.01% 2291
2022
Q2
$1.55M Sell
33,395
-18,594
-36% -$974K ﹤0.01% 3292
2022
Q1
$2.98M Sell
51,989
-35,605
-41% -$1.83M ﹤0.01% 2901
2021
Q4
$4.62M Sell
87,594
-13,923
-14% -$745K ﹤0.01% 2460
2021
Q3
$5.09M Buy
101,517
+9,741
+11% +$505K ﹤0.01% 2089
2021
Q2
$5.39M Sell
91,776
-87,306
-49% -$5.4M ﹤0.01% 1966
2021
Q1
$11.7M Sell
179,082
-61,358
-26% -$3.77M 0.01% 1255
2020
Q4
$13.2M Sell
240,440
-11,941
-5% -$609K 0.01% 1207
2020
Q3
$11.1M Sell
252,381
-40,827
-14% -$1.79M 0.01% 1177
2020
Q2
$12.4M Sell
293,208
-36,863
-11% -$1.42M 0.01% 1063
2020
Q1
$13.1M Buy
330,071
+104,628
+46% +$4.42M 0.02% 847
2019
Q4
$10M Buy
225,443
+98,182
+77% +$3.78M 0.01% 1204
2019
Q3
$4.35M Buy
127,261
+7,431
+6% +$257K 0.01% 1754
2019
Q2
$4.51M Sell
119,830
-44,985
-27% -$1.54M 0.01% 1659
2019
Q1
$5.04M Sell
164,815
-112,605
-41% -$3.44M 0.01% 1549
2018
Q4
$7.68M Buy
+277,420
New +$7.62M 0.01% 1255

Other funds holding ACA

D.E. Shaw & Co's ACA Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Arcosa (ACA) stake by 73% in Q1 2026, selling an estimated $2.88M and leaving 9,224 shares worth $979K. The position accounts for ﹤0.01% of the portfolio, ranked #3463.

D.E. Shaw & Co first reported a position in ACA in Q4 2018 and has held it in 30 quarters since. The position peaked at $13.2M in Q4 2020. 372 funds tracked by Wall St. Rank hold ACA as of Q1 2026.

  • D.E. Shaw & Co held 9,224 shares of Arcosa worth $979K as of Q1 2026.
  • D.E. Shaw & Co sold 25,310 Arcosa shares in Q1 2026, an estimated $2.88M.
  • Arcosa made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #3463 holding.
  • D.E. Shaw & Co first reported a position in Arcosa in Q4 2018 and has held it in 30 quarters since.
  • D.E. Shaw & Co's Arcosa position peaked at $13.2M in Q4 2020.
  • 372 funds tracked by Wall St. Rank held Arcosa as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.